Shanghai Pharmaceuticals Holding Co Ltd (601607) — Cash Flow Quality Index
Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Cash Flow Quality Index of 2.26x as of September 2025. Operating cash flow of CN¥1.56 Billion exceeds net income of CN¥688.20 Million, indicating high earnings quality where cash backs reported profits. Explore Shanghai Pharmaceuticals Holding Co Ltd cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Pharmaceuticals Holding Co Ltd Cash Flow Quality Index (1998–2025)
Historical Cash Flow Quality Index for Shanghai Pharmaceuticals Holding Co Ltd across 28 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Shanghai Pharmaceuticals Holding Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)
Year-by-year earnings quality comparison for Shanghai Pharmaceuticals Holding Co Ltd. For live market cap and the full company financial profile, see market value of Shanghai Pharmaceuticals Holding Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.08x | CN¥6.15 Billion | CN¥5.72 Billion | ▲ +8.3% |
| 2024 | 0.99x | CN¥5.83 Billion | CN¥5.87 Billion | ▼ -28.5% |
| 2023 | 1.39x | CN¥5.23 Billion | CN¥3.77 Billion | ▲ +104.7% |
| 2022 | 0.68x | CN¥4.74 Billion | CN¥6.99 Billion | ▼ -15.9% |
| 2021 | 0.81x | CN¥5.06 Billion | CN¥6.27 Billion | ▼ -33.9% |
| 2020 | 1.22x | CN¥6.84 Billion | CN¥5.61 Billion | ▼ -2.0% |
| 2019 | 1.25x | CN¥6.02 Billion | CN¥4.83 Billion | ▲ +77.2% |
| 2018 | 0.70x | CN¥3.14 Billion | CN¥4.46 Billion | ▲ +7.8% |
| 2017 | 0.65x | CN¥2.65 Billion | CN¥4.06 Billion | ▲ +28.4% |
| 2016 | 0.51x | CN¥1.95 Billion | CN¥3.83 Billion | ▲ +26.8% |
| 2015 | 0.40x | CN¥1.35 Billion | CN¥3.36 Billion | ▼ -10.2% |
| 2014 | 0.45x | CN¥1.34 Billion | CN¥2.99 Billion | ▲ +20.5% |
| 2013 | 0.37x | CN¥973.45 Million | CN¥2.63 Billion | ▼ -20.8% |
| 2012 | 0.47x | CN¥1.15 Billion | CN¥2.46 Billion | ▼ -35.5% |
| 2011 | 0.72x | CN¥1.77 Billion | CN¥2.45 Billion | ▼ -23.5% |
| 2010 | 0.95x | CN¥1.69 Billion | CN¥1.78 Billion | ▼ -62.4% |
| 2009 | 2.52x | CN¥664.13 Million | CN¥263.48 Million | ▲ +14.2% |
| 2008 | 2.21x | CN¥285.68 Million | CN¥129.43 Million | ▼ -56.9% |
| 2007 | 5.12x | CN¥488.94 Million | CN¥95.48 Million | ▼ -20.5% |
| 2006 | 6.44x | CN¥583.11 Million | CN¥90.54 Million | ▲ +529.9% |
| 2005 | 1.02x | CN¥73.00 Million | CN¥71.40 Million | ▲ +129.7% |
| 2004 | 0.45x | CN¥61.66 Million | CN¥138.51 Million | ▲ +18973.7% |
| 2003 | 0.00x | CN¥484.27K | CN¥207.48 Million | ▼ -99.6% |
| 2002 | 0.62x | CN¥100.84 Million | CN¥163.07 Million | ▲ +64.4% |
| 2001 | 0.38x | CN¥65.73 Million | CN¥174.77 Million | ▼ -47.4% |
| 2000 | 0.71x | CN¥146.22 Million | CN¥204.65 Million | ▼ -51.9% |
| 1999 | 1.49x | CN¥164.67 Million | CN¥110.84 Million | ▲ +147.1% |
| 1998 | -3.15x | CN¥-283.14 Million | CN¥89.83 Million | — |